Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 2:38 AM UTC
| NCT Number | NCT02227251 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 244 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | May 6, 2026 (3 weeks ago) |
As of June 2, 2026: Clinical trial NCT02227251 is currently active_not_recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is not currently accepting new participants at 23 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02227251 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02227251 was last updated 3 weeks ago (May 6, 2026). HelloStudys verifies this status automatically.